OOIR: Observatory of International Research

Papers

(The H4-Index of Critical Reviews in Oncology Hematology is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Research update for ferroptosis and cholangiocarcinoma	165
Genomic biology and therapeutic strategies of liver metastasis from gastric cancer	153
Development of treatment strategies for advanced HER2-positive gastric cancer: Insights from clinical trials	128
Impact of molecular testing on the surgical management of advanced epithelial ovarian cancer	120
Factors for a broad technology assessment of comprehensive genomic profiling in advanced cancer, a systematic review	102
Editorial Board	93
HER2-targeted therapies: Unraveling their role in biliary tract cancers	79
Molecular biomarkers in prostate cancer tumorigenesis and clinical relevance	77
The role of hyperthermia in the treatment of tumor	73
Hurrying up but not rushing, acting and not reacting, good sense and not common sense: Open thoughts and reasonable doubts on COVID-19 vaccination strategies in cancer patients	66
The applications of plasma cell-free DNA in cancer detection: Implications in the management of breast cancer patients	64
What is the role of physical exercise in the era of cancer prehabilitation? A systematic review	59
Multigenic panels in breast cancer: Clinical utility and management of patients with pathogenic variants other than BRCA1/2	58
Management of bone disease with concurrent chimeric antigen receptor T-cell therapy for multiple myeloma	56
Targeted immunotherapy to cancer stem cells: A novel strategy of anticancer immunotherapy	55
Colorectal cancer with BRAF V600E mutation: Trends in immune checkpoint inhibitor treatment	55
STAT3 orchestrates immune dynamics in hepatocellular carcinoma: A pivotal nexus in tumor progression	53
Recent strategies to overcome breast cancer resistance	53
Current status of locally advanced rectal cancer therapy and future prospects	50
Targeting androgen receptor in glioblastoma	50
Application of molecular imaging in immune checkpoints therapy: From response assessment to prognosis prediction	50
Comprehensive approach to cancer immunotherapy – Simultaneous targeting of myeloid-derived suppressor cells and cancer cells with AFP conjugates	49
Geriatric predictors of response and adverse events in older patients with cancer treated with immune checkpoint inhibitors: A systematic review	48
Immune checkpoint inhibitors therapy as the game-changing approach for pediatric lymphoma: A brief landscape	48
Progress and prospects of flattening filter free beam technology in radiosurgery and stereotactic body radiotherapy	47

Adjuvant chemotherapy after neoadjuvant chemo-radiotherapy and surgery in locally advanced rectal cancer. A systematic review of literature with a meta-analysis of randomized clinical trials	45
Targeting mitochondrial dysfunctions in pancreatic cancer evokes new therapeutic opportunities	45
Real-world evidence in extensive disease small cell lung cancer: The missing piece of the puzzle	45
From preclinical efficacy to 2022 (36.7 months median follow -up) updated CROWN trial, lorlatinib is the preferred 1st-line treatment of advanced ALK+ NSCLC	43
Evaluation of first-line and salvage therapies for unresectable malignant mesothelioma: A systematic review and network meta-analysis	43
The role of PARP inhibitors in gastrointestinal cancers	40
Dose and volume de-escalation of radiotherapy in head and neck cancer	39
A Systematic Review on Intensity Modulated Radiation Therapy for Mediastinal Hodgkin’s Lymphoma	38
Comprehensive review of solid tumor bone marrow metastasis	38
Theragnostic strategies harnessing the self-renewal pathways of stem-like cells in the acute myeloid leukemia	37
Overcoming barriers to timely recognition and treatment of cancer cachexia: Sharing Progress in Cancer Care Task Force Position Paper and Call to Action	37
Stereotactic body radiation therapy versus conventional external beam radiation therapy for painful bone metastases: A systematic review and meta-analysis of randomized trials	36
High dose chemotherapy followed by autologous hematopoietic stem cell transplantation for advanced germ cell tumors: State of the art and a single-center experience	36